ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026
[Application of optical genome mapping technology in the genetic diagnosis of a family with a cryptic complex chromosomal balanced translocations].
Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesFor couples with recurrent adverse pregnancy outcomes but normal results on conventional karyotype analysis, the underlying genetic causes (such as cryptic chromosomal balanced translocations) are difficult to identify using traditional methods. These complex structure variations are often missed due to resolution limitations, posing a major challenge in clinical genetic diagnosis. This study aims to perform genetic etiological diagnosis and provide reproductive guidance for a couple with two abnormal reproductive histories, and to evaluate the application value of optical genome mapping (OGM) in the field of reproductive genetics.
methodsClinical data were collected from a couple who attended the Reproductive Medicine Center, First Hospital of Lanzhou University, with two consecutive adverse pregnancy outcomes and seeking genetic diagnosis. Previous results from ultrasonography, chromosomal karyotyping, copy number variation sequencing (CNV-seq), and fluorescence in situ hybridization (FISH) were reviewed. OGM was further performed on peripheral blood samples from both partners to conduct high-resolution, genome-wide structural variation analysis, in order to assess the clinical utility of OGM in detecting cryptic chromosomal balanced translocations, particularly complex structure variations.
resultsCNV-seq results from the 2 pregnancies showed del(4)(p16.3), 3.80 Mb, and dup(4)(p16.3), 3.74 Mb combined with del(22)(q13.31-q13.33), 4.64 Mb, respectively. Conventional chromosomal karyotyping of peripheral blood from both parents revealed no obvious abnormalities, suggesting the possibility of a cryptic chromosomal balanced translocation carrier. OGM analysis demonstrated that the male partner carried a cryptic complex balanced translocation involving chromosomes 1, 4, and 22. The breakpoints were located in regions consistent with the boundaries of the abnormal CNV segments identified in both fetuses. These findings confirmed that the male partner was a phenotypically normal carrier of a complex balanced translocation, and that the chromosomal abnormalities in both fetuses resulted from unbalanced segregation of derivative chromosomes during parental meiosis.
conclusionsAs a novel non-sequencing-based genomic technology characterized by high resolution, ultra-long read length, and automation, OGM is more efficient than traditional cytogenetic techniques in detecting cryptic balanced translocations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.